Mint Tower Capital Management B.V. Merus N.V. Transaction History
Mint Tower Capital Management B.V.
- $844 Million
- Q3 2025
A detailed history of Mint Tower Capital Management B.V. transactions in Merus N.V. stock. As of the latest transaction made, Mint Tower Capital Management B.V. holds 20,000 shares of MRUS stock, worth $1.92 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$1.92 Million% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
262Shares Held
62.3MCall Options Held
1.04MPut Options Held
451K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$420 Million13.26% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.54MShares$340 Million4.56% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$338 Million21.18% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.05MShares$292 Million5.34% of portfolio
-
Hbk Investments L P Dallas, TX2.85MShares$273 Million3.71% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $4.4B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...